| Israele | Turchia | Austria | |
| Tumorectomia | da $12,510 | da $2,700 | da $8,500 |
| Mastectomia | da $12,510 | da $4,500 | da $10,000 |
| Immunoterapia con Keytruda (Pembrolizumab) | da $9,800 | da $3,300 | da $15,000 |
| CyberKnife | da $17,500 | da $4,750 | da $50,000 |
| Coltello Gamma | da $13,800 | da $6,300 | da $32,000 |
Oltre 30 anni al Sourasky Medical Center specializzato nel cancro al seno – il Dott. Merimsky è Professore Associato ed ex Presidente di Oncologia.
Il medico è specializzato in ginecologia oncologica e radioterapia, concentrandosi sul trattamento e la gestione dei tumori ginecologici. Con un'ampia esperienza nelle tecniche avanzate di radioterapia, il medico ha contribuito a migliorare i risultati dei pazienti attraverso approcci innovativi nella cura del cancro. Il medico è riconosciuto per il suo impegno nell'integrare la ricerca all'avanguardia nella pratica clinica, garantendo che i pazienti ricevano i trattamenti più efficaci e aggiornati disponibili.<\/p>
Il medico è un praticante altamente esperto presso il Sourasky Medical Center, specializzato in Medicina Interna e Cardiologia. Con oltre 20 anni di esperienza, il medico è certificato in entrambi i campi. Il focus clinico include Cardiologia, Pneumologia e Medicina Critica, fornendo cure complete per una vasta gamma di malattie e condizioni.<\/p>
Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.
Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.
Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.
Israel reports a five-year breast cancer survival rate between 88% and 89.4%. The breast preservation rate for early-stage cases is approximately 75%. Leading facilities like Sourasky Medical Center report survival reaching up to 90.7% for women under 60 due to advanced early-detection protocols.
Bookimed Expert Insight: While national averages are high, Israeli specialists like Dr Sonnenblick Amir and Prof Schlomo Schneebaum focus on subtype-specific outcomes. Patients with HER2-positive or triple-negative cancers often receive personalised immunotherapy or targeted therapy protocols. These advanced treatments are a standard part of the multidisciplinary approach at JCI-accredited centres like Assuta or Sheba.
Patient Consensus: Patients note that Israel offers very fast access to blood tests and PET/CT scans. They often suggest getting a second pathology review in Israel to confirm the tumour subtype before surgery.
Israeli clinics offer advanced breast cancer treatments including CAR-T cell immunotherapy, MR Linac guided radiation, and intraoperative radiotherapy. Precision medicine via genomic profiling allows specialists to tailor targeted biological therapies. High-volume centres like Sourasky Medical Center and Sheba Medical Center provide these innovations alongside robotic organ-preserving surgeries.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky handle massive patient volumes, with Sheba serving over 2,000,000 people annually. This high turnover means local specialists like Dr Ari Raphael or Dr Tamar Sapra see rare breast cancer subtypes daily. For Australians, this density of experience often translates to more accurate staging and faster access to new drug protocols than at home.
Patient Consensus: Patients value the rapid diagnostic turnaround for pathology and imaging in Israel. They highlight the importance of coordinating reconstruction plans and tumour marker tracking with Australian doctors before returning home.
Immediate breast reconstruction is available in Israel during cancer surgery. Surgeons perform this procedure concurrently with a mastectomy or lumpectomy. This allows patients to wake with a breast mound in place. Specialist teams at centres like Sourasky Medical Center coordinate these complex surgeries.
Bookimed Expert Insight: Israeli oncology centres like Sourasky perform over 400,000 cases annually. Data shows that high-volume hospitals often employ multi-specialty teams including oncologists like Dr Ari Raphael. This coordination is vital because radiation plans can alter reconstruction timing. Patients should confirm if their surgeon collaborates with a plastic specialist who has 20+ years of experience.
Patient Consensus: Patients note Israeli doctors are very tactful and provide excellent emotional support during the recovery process. Many emphasize that having advanced equipment and qualified specialists in Tel Aviv helps them feel confident about their surgical outcomes in Israel.
Israeli hospitals manage the breast cancer diagnostic process through accelerated protocols. Leading centres like Sourasky Medical Center and Sheba Medical Center coordinate lab tests, PET-CT scans, and biopsies within a condensed window. This system ensures patients receive a definitive treatment plan shortly after arrival in Israel.
Bookimed Expert Insight: While many expect a simple confirmation, for breast cancer, the first visit in Israel acts as a high-precision staging check. Major hubs like Sheba Medical Center treat over 2,000,000 patients annually. They use this volume to maintain efficient, same-week diagnostic pipelines that help Australians avoid the long wait times common for complex screenings at home.
Patient Consensus: Patients note the process in Israel is fast and intense. Bringing physical biopsy blocks and digital imaging links helps ensure appointments at Sourasky Medical Center or Assuta run without delays.
Israeli hospitals provide international patient departments to coordinate the entire medical journey. Support includes pre-travel medical record reviews, visa assistance, and airport transfers. Patients receive personalized case management, English-speaking staff, and digital follow-up through platforms like Sheba Beyond. These services streamline complex treatments such as oncology.
Bookimed Expert Insight: Israeli hospitals often report higher patient volumes than most European centres. Sourasky Medical Center treats 400,000 patients and Sheba serves 2 million annually. This high volume means their international departments are exceptionally fast. They can often organise complex oncology diagnostics and specialist consultations within days of a patient landing.
Patient Consensus: Patients note the treatment process in Israel is very fast and efficient. They appreciate the sincere attitude of the staff and the helpful nature of the coordination teams. Many found that having a dedicated person to manage scheduling and transport made a difficult journey much easier.